Provided by Tiger Trade Technology Pte. Ltd.

ASCLETIS-B

8.365
+0.0650.78%
Volume:2.13M
Turnover:17.73M
Market Cap:8.80B
PE:-19.35
High:8.510
Open:8.295
Low:8.135
Close:8.300
52wk High:19.860
52wk Low:7.950
Shares:1.05B
HK Float Shares:1.05B
Volume Ratio:1.84
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.432
ROE:-28.59%
ROA:-19.64%
PB:3.32
PE(LYR):-19.35
PS:7955.01

Loading ...

ASCLETIS-B Presents Compelling Clinical and Preclinical Data for Obesity Portfolio at ADA 2026, Reinforcing Pipeline Differentiation

Stock News
·
Jun 08

Ascletis Highlights Robust Obesity Pipeline with Positive ASC30, ASC37 and ASC39 Results at ADA 2026

Bulletin Express
·
Jun 08

Ascletis | Key Resolutions and Timetable for the 2026 Annual General Meeting

Bulletin Express
·
Jun 05

Ascletis Pharma to Hold 2026 AGM; Seeks 20% Share Issuance Mandate, 10% Buy-Back Authority and Director Re-elections

Bulletin Express
·
Jun 05

HK Movers | Biotech Stocks Jump. Asymchem up Nearly 7%; SKB Bio up About 6%; Hengrui Pharma, Pharmaron, InnoGen up over 4%; Wuxi Apptec up 3%; Laekna, Joinn, Remegen up over 2%

Tiger Newspress
·
Jun 05

ASCLETIS-B Executes Share Buyback Valued at Approximately HK$2.03 Million

Stock News
·
Jun 04

Ascletis Pharma files HKEX next-day disclosure return, reports share buyback at HKD 10.31-9.8 each

Reuters
·
Jun 04

Ascletis Pharma spends HK$2.01 million on latest buyback; cumulative repurchases reach 6.69 million shares

Bulletin Express
·
Jun 03

Ascletis-B buys back 0.20 million shares for HK$2.06 million; cumulative repurchases reach 0.67% of share base

Bulletin Express
·
Jun 02

ASCLETIS-B Executes Share Buyback, Spending HK$2.06 Million on 200,000 Shares

Stock News
·
Jun 02

Ascletis files HKEX next-day return disclosing share buyback at HKD 9.98-10.54 per share

Reuters
·
Jun 02

Ascletis Pharma proposes bylaw changes to allow hybrid shareholder meetings, e-voting

Reuters
·
Jun 02

Ascletis-B Maintains Stable Share Structure in May 2026; Public Float Confirmed Above 25%

Bulletin Express
·
Jun 01

ASCLETIS-B Shares Surge Over 5% in Early Trading as GIC Boosts Stake to 7% and U.S. Phase II Study Completes Enrollment

Stock News
·
May 21

GIC Private Limited Increases Stake in Ascletis-B (01672) by 122,000 Shares at HK$16.612 Each

Stock News
·
May 12

Citigroup: Fundamentals of China's Healthcare Sector Show Sustained Improvement, Top Picks Include WuXi AppTec (02359)

Stock News
·
May 11

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress
·
May 11

ASCLETIS-B Adds 0.24 Million Shares from Option Exercises; Public Float Remains Compliant

Bulletin Express
·
May 07

Hong Kong Stock Announcement Highlights | TESSON HOLDINGS Subsidiary Signs MOU with DST to Establish JV for Hong Kong New Energy Charging and Battery Swap Network, First Phase to Build 10 Multi-Functional Stations

Stock News
·
May 06

ASCLETIS-B (01672) to Present Multiple Program Data at 33rd European Congress on Obesity (ECO 2026)

Stock News
·
May 06